Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Matthieu Allez

Showing results (21-30 of 205) with videos related to

Pageof 21
Sort By:
Digestive Diseases (Basel, Switzerland)|November 20, 2013
Endoscopy as a prognostic marker in inflammatory bowel diseaseMarine Camus, Benjamin Pariente, Xavier Dray, et al.
Gastroenterologie Clinique Et Biologique|June 24, 2004
[Bone and joints in inflammatory bowel disease]Marc Lemann, Joëlle Bonnet, Matthieu Allez, et al.
Annals of the New York Academy of Sciences|February 1, 2005
Activation of a unique population of CD8(+) T cells by intestinal epithelial cellsMatthieu Allez, Jens Brimnes, Ling Shao, et al.
The American Journal of Gastroenterology|May 11, 2002
Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopyMatthieu Allez, Marc Lemann, Joëlle Bonnet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel diseaseJens Brimnes, Matthieu Allez, Iris Dotan, et al.
Journal of Crohn'S & Colitis|July 30, 2020
Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 PandemicMatthieu Allez, Phillip Fleshner, Richard Gearry, et al.
Medicinal Research Reviews|June 20, 2019
The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapiesIris Dotan, Matthieu Allez, Silvio Danese, et al.
The Journal of Dermatological Treatment|April 25, 2015
Certolizumab pegol - A new therapeutic option for refractory disseminated pyoderma gangrenosum associated with Crohn's diseaseCharlotte Hurabielle, Pierre Schneider, Clotilde Baudry, et al.
Gut|October 11, 2018
Rare cause of rectal stenosis in a patient with long-term use of Infliximab and Mercaptopurine for ulcerative colitisNassim Hammoudi, Charlotte Gardair, My-Linh Tran-Minh, et al.
Gut|August 5, 2016
Anti-NKG2D monoclonal antibody (NNC0142-0002) in active Crohn's disease: a randomised controlled trialMatthieu Allez, Brett E Skolnick, Maria Wisniewska-Jarosinska, et al.
Pageof 21

Showing results (21-30 of 205) with videos related to

Sort By:
Pageof 21
Digestive Diseases (Basel, Switzerland)|November 20, 2013
Endoscopy as a prognostic marker in inflammatory bowel diseaseMarine Camus, Benjamin Pariente, Xavier Dray, et al.
Gastroenterologie Clinique Et Biologique|June 24, 2004
[Bone and joints in inflammatory bowel disease]Marc Lemann, Joëlle Bonnet, Matthieu Allez, et al.
Annals of the New York Academy of Sciences|February 1, 2005
Activation of a unique population of CD8(+) T cells by intestinal epithelial cellsMatthieu Allez, Jens Brimnes, Ling Shao, et al.
The American Journal of Gastroenterology|May 11, 2002
Long term outcome of patients with active Crohn's disease exhibiting extensive and deep ulcerations at colonoscopyMatthieu Allez, Marc Lemann, Joëlle Bonnet, et al.
Journal of Immunology (Baltimore, Md. : 1950)|April 22, 2005
Defects in CD8+ regulatory T cells in the lamina propria of patients with inflammatory bowel diseaseJens Brimnes, Matthieu Allez, Iris Dotan, et al.
Journal of Crohn'S & Colitis|July 30, 2020
Care of the Patient With IBD Requiring Hospitalisation During the COVID-19 PandemicMatthieu Allez, Phillip Fleshner, Richard Gearry, et al.
Medicinal Research Reviews|June 20, 2019
The role of integrins in the pathogenesis of inflammatory bowel disease: Approved and investigational anti-integrin therapiesIris Dotan, Matthieu Allez, Silvio Danese, et al.
The Journal of Dermatological Treatment|April 25, 2015
Certolizumab pegol - A new therapeutic option for refractory disseminated pyoderma gangrenosum associated with Crohn's diseaseCharlotte Hurabielle, Pierre Schneider, Clotilde Baudry, et al.
Gut|October 11, 2018
Rare cause of rectal stenosis in a patient with long-term use of Infliximab and Mercaptopurine for ulcerative colitisNassim Hammoudi, Charlotte Gardair, My-Linh Tran-Minh, et al.
Gut|August 5, 2016
Anti-NKG2D monoclonal antibody (NNC0142-0002) in active Crohn's disease: a randomised controlled trialMatthieu Allez, Brett E Skolnick, Maria Wisniewska-Jarosinska, et al.
Pageof 21